LJ-2698

CAT: 0931-T202459-01Size: 10 mgDry Ice: NoHazardous: No
CAT#:0931-T202459-01Size:10 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
945457-84-1
Bioactivity
LJ-2698 is an adenosine A3 receptor antagonist under investigation for treating emphysema and DKD (Diabetic Kidney Disease) . In mouse lung models, LJ-2698 effectively mitigates elastase-induced adverse effects and inhibits matrix metalloproteinase activity and apoptosis. Additionally, it is being explored for its potential in treating diabetic nephropathy, successfully preventing various types of kidney damage in mice.
Smiles
N(CC1=CC(Cl)=CC=C1)C2=C3C(N(C=N3)[C@H]4[C@H](O)[C@H](O)CS4)=NC(Cl)=N2
Molecular Formula
C16H15Cl2N5O2S
Molecular Weight
412.29
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
T32804-01LJ-001
T32802LJ 1121
T61914-01LJ-4517
T32803LJ 278
T26411-01A 269A
T16343-01NRC-2694
T23024MRS 2690
T71332-01NRC-2694 hydrochloride
T71331-01NRC-2694 dihydrochloride
T3S2007-01MRE-269

Alternative Products

CatalogName
MBS5782368LJ 278
MBS3606181-01LJ 001
BUP08188-01LJ-001
MBS5804606LJ-4517
MBS5782367LJ 1121
MED1152Non-acidified Pyruvate LJ Med
MBS384135-01Alvimopan (ADL 8-2698)
MED1150Non-acidified Glycerol LJ Med
A11292-2Alvimopan (ADL 8-2698) 2mg
A11292-500Alvimopan (ADL 8-2698) 500mg

Popular Products